BIG NEWS: Drug up for FDA Approval for NF1 Plexiforms
Big news just hit…though it has been expected! Many of us have been following the success of the drug selumetinib…
Read MoreBig news just hit…though it has been expected! Many of us have been following the success of the drug selumetinib…
Read MoreOur 2018 financial statement is complete and we’ve taken time to look back at the year in review! It was…
Read MoreCheck out our Spring 2019 NF Midwest Newsletter! The highlights of this issue include… Page 1 Information on the new…
Read MoreIf you have a child with neurofibromatosis, please consider sending them to Camp New Friends. Now is the time to…
Read MoreProtect federal funds for neurofibromatosis by acting now! Fill out the form below to Raise your Voice for NF Research….
Read MoreBecause the neurofibromatosis cause needs New Fighters and young iNFluencers! See photos This January I had the extreme privilege of…
Read MoreIf you’re a post high school student with neurofibromatosis or schwannomatosis, and you live in NF Midwest’s service region of…
Read MoreWhich nonprofits have you wanted to help this year? You probably have a list of your favorites! Supporting those meaningful…
Read MoreThis past February, NF Midwest brought volunteers to Washington DC to once again advocate for federal dollars for neurofibromatosis type…
Read MoreNeurofibromatosis Midwest is excited to award $1,000 academic scholarships to six adults affected by neurofibromatosis or schwannomatosis. This is the fourth…
Read More
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.